$3.38
-0.10-2.87%
At close: -
$5.29
1.9156.51%
After Hours: May 6, 7:40 AM EDT
Comments
Loading...
Kalaris Therapeutics Stock Guidance | NASDAQ:KLRS | Benzinga
Kalaris Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kalaris Therapeutics Inc (KLRS) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Kalaris Therapeutics (KLRS)?
There have been no specific sales or earnings guidance reported for Kalaris Therapeutics in recent months.
Browse guidance and forecast on all stocks.
